Literature DB >> 8555484

Thrombin-induced GPIb-IX centralization on the platelet surface requires actin assembly and myosin II activation.

T J Kovacsovics1, J H Hartwig.   

Abstract

In resting platelets, the GPIb-IX complex, the receptor for the von Willebrand factor (vWF), is linked to underlying actin filaments by actin-binding protein (ABP-280). Thrombin stimulation of human platelets leads to a decrease in the surface expression of the GPIb-IX complex, which is redistributed from the platelet surface into the open canalicular system (OCS). Because the centralization of GPIb-IX is inhibited by cytochalasin, it is believed to be linked to actin cytoskeletal rearrangements that take place during platelet activation. We have further characterized the mechanism of GPIb-IX centralization in platelets in suspension. Following thrombin stimulation, GPIb-IX shifts from the membrane skeleton of the resting cell to the cytoskeleton of the activated cell in a reaction sensitive to cytochalasin B. The cytoskeletal association of GPIb-IX involves ABP-280, as it correlates with the incorporation of ABP-280 into the activated cytoskeleton and because no dissociation of the ABP-280/GPIb-IX complexes is detected after thrombin activation. However, the incorporation of GPIb-IX into the cytoskeleton is complete within 1 minute, whereas GPIb-IX centralization requires 5 to 10 minutes for completion. The movement of GPIb-IX to the cytoskeleton of activated platelets is therefore necessary, but not sufficient for GPIb-IX centralization. Blockage of cytosolic calcium increases induced by thrombin by loading with the cell permeant calcium chelator Quin-2 AM inhibited GPIb-IX centralization by 70%, but did not prevent its association with the activated cytoskeleton. Quin-2 loading did, however, decrease the incorporation of myosin II into the activated cytoskeleton. The role of myosin II was further probed using the myosin light chain kinase (MLCK) inhibitor wortmannin. Wortmannin prevents myosin II association to the activated cytoskeleton and inhibits GPIb-IX centralization by 50%, without affecting actin assembly or the association of GPIb-IX to the cytoskeleton. Only micromolar concentrations of wortmannin, high enough to inhibit MLCK, prevent GPIb-IX centralization. These results indicate that thrombin-induced GPIb-IX centralization requires a minimum of two steps, one associating GPIb-IX to the activated cytoskeleton and the second requiring myosin II activation. The involvement of myosin II implies that GPIb-IX/ABP-280 complexes, linked to actin filaments, are pulled into the cell center, and that platelets may exert contractile tension on vWF bound to its receptor.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8555484

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

Review 1.  Platelet GP Ib/IX/V complex: physiological role.

Authors:  J Rivera; M L Lozano; J Corral; R González-Conejero; C Martínez; V Vicente
Journal:  J Physiol Biochem       Date:  2000-12       Impact factor: 4.158

2.  The structure of the GPIb-filamin A complex.

Authors:  Fumihiko Nakamura; Regina Pudas; Outi Heikkinen; Perttu Permi; Ilkka Kilpeläinen; Adam D Munday; John H Hartwig; Thomas P Stossel; Jari Ylänne
Journal:  Blood       Date:  2005-11-17       Impact factor: 22.113

3.  LNK (SH2B3) is a key regulator of integrin signaling in endothelial cells and targets α-parvin to control cell adhesion and migration.

Authors:  Julie Devallière; Mathias Chatelais; Juliette Fitau; Nathalie Gérard; Philippe Hulin; Laura Velazquez; Christopher E Turner; Béatrice Charreau
Journal:  FASEB J       Date:  2012-03-21       Impact factor: 5.191

4.  Regulation of LIM-kinase 1 and cofilin in thrombin-stimulated platelets.

Authors:  Dharmendra Pandey; Pankaj Goyal; James R Bamburg; Wolfgang Siess
Journal:  Blood       Date:  2005-10-11       Impact factor: 22.113

5.  LIM kinase-1 selectively promotes glycoprotein Ib-IX-mediated TXA2 synthesis, platelet activation, and thrombosis.

Authors:  Brian Estevez; Aleksandra Stojanovic-Terpo; M Keegan Delaney; Kelly A O'Brien; Michael C Berndt; Changgeng Ruan; Xiaoping Du
Journal:  Blood       Date:  2013-04-25       Impact factor: 22.113

6.  Regulation of actin polymerization by tropomodulin-3 controls megakaryocyte actin organization and platelet biogenesis.

Authors:  Zhenhua Sui; Roberta B Nowak; Chad Sanada; Stephanie Halene; Diane S Krause; Velia M Fowler
Journal:  Blood       Date:  2015-05-11       Impact factor: 22.113

Review 7.  Actin dynamics in platelets.

Authors:  E L Bearer; J M Prakash; Z Li
Journal:  Int Rev Cytol       Date:  2002

8.  Protease activated receptors in cardiovascular function and disease.

Authors:  Junor A Barnes; Shamjeet Singh; Aldrin V Gomes
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

9.  Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes.

Authors:  J E Italiano; P Lecine; R A Shivdasani; J H Hartwig
Journal:  J Cell Biol       Date:  1999-12-13       Impact factor: 10.539

10.  Structural basis of filamin A functions.

Authors:  Fumihiko Nakamura; Teresia M Osborn; Christopher A Hartemink; John H Hartwig; Thomas P Stossel
Journal:  J Cell Biol       Date:  2007-12-03       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.